CORONAVIRUS DISEASE COVID 19 NEWS AND RESEARCH
Latest Coronavirus Disease COVID 19 News and Research
EKF introduces novel molecular transport media for dual COVID-19 and influenza sampling
EKF Diagnostics the global in vitro diagnostics company, announces that it has added a novel viral transport media for the safe sample handling and testing of multiple infectious diseases from a single swab to its product range.
Adding to COVID stress, families of health workers fight for denied workers’ comp benefits
James “Mike” Anderson was a hospital employee in suburban Philadelphia with a low-profile though critical job: changing air filters in COVIAdding To COVID Stress, Families Of Health Workers Fight For Denied Workers’ Comp BenefitsCOVID cases in Bucks County, Pennsylvania, had ramped up to as many as 90 per day.
Standardized packaging and stricter taxation measures reduce cigarette sales
The introduction of standardized packaging for cigarettes in the UK, combined with stricter taxation measures on cheaper cigarettes, has led to a significant fall in sales for cigarettes, according to a new analysis from researchers at the University of Bath.
South Carolina reports first cases of coronavirus-related pediatric inflammatory syndrome
Coronavirus-related pediatric inflammatory syndrome, also known as multisystem inflammatory syndrome in children, or MIS-C, is a rare inflammatory condition that affects children and adolescents and is tied to exposure to the novel coronavirus.
Researchers develop COVID-19 mortality risk calculator
A new study published in July 2020 on the preprint server medRxiv describes the use of machine learning to provide a better understanding of the risk factors in large and mixed groups. The use of algorithms can help objectively evaluate these factors and perhaps capture interactions that could be missed in a purely observational study.
_719f12201b904794b1a8a8834308ce5f-150x125.jpg "Dysfunctional T cells present at high levels in severe COVID-19")
Dysfunctional T cells present at high levels in severe COVID-19
Now, a new study by researchers at Saarland University, Germany, and published on the preprint server medRxiv in July 2020 shows that there are higher levels of anti-SARS-CoV-2 T cells, which show significant alterations in the phenotype and function.
No unique viral sequences found in pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2
In contrast to previous hypotheses, researchers from the University College London and Great Ormond Street Hospital for Children NHS Foundation Trust found no evidence of unique viral sequences from patients with pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS). Their study is published on the medRxiv* preprint server.
Digestive manifestations common but mild among hospitalized COVID-19 patients
A team of 121 researchers from the United States and Canada reports that while digestive manifestations seem to be common among people hospitalized with coronavirus disease 2019 (COVID-19), the majority appear to be mild and not associated with severe clinical outcomes.
Increasing level of SARS-CoV-2 detected in Montpellier wastewater
Researchers at The French National Centre for Scientific Research have identified a recent increase in the amount of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA at the main wastewater treatment plant (WWTP) of the Montpellier metropolitan area.
Global government COVID-19 interventions - no one-fits-all solution exists
A new study published on the preprint server medRxiv in July 2020 shows that some less intrusive NPIs are better than total lockdown. This may help to shape future measures should repeated waves of the pandemic occur.
Study documents intrauterine transmission of SARS-CoV-2 infection during pregnancy
A baby girl in Texas - born prematurely to a mother with COVID-19 - is the strongest evidence to date that intrauterine (in the womb) transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can occur, reports The Pediatric Infectious Disease Journal, the official journal of The European Society for Paediatric Infectious Diseases.
Concentration of lopinavir and hydroxychloroquine not sufficient to fight novel coronavirus
Lopinavir is a drug against HIV, hydroxychloroquine is used to treat malaria and rheumatism. Until recently, both drugs were regarded as potential agents in the fight against the coronavirus SARS-CoV-2.
Laboratory testing confirms effectiveness of BETADINE antiseptic products against SARS-CoV-2
Mundipharma today announced that laboratory testing at the Duke-NUS Medical School in Singapore, has confirmed the effectiveness of its BETADINE antiseptic products against the novel coronavirus (SARS-CoV-2) which causes COVID-19 disease.
Charity warns of a catastrophic knock on effect for stroke research due to pandemic
Almost three quarters (74%) of stroke research projects funded by the Stroke Association have been suspended because of the coronavirus pandemic.
Colorado, like other states, trims health programs amid health crisis
As a teenager, Paulina Castle struggled for years with suicidal thoughts. When her mental health was at its most fragile, she would isolate herself, spending days in her room alone.
New clinical trial to assess safety and efficacy of convalescent plasma to prevent COVID-19
There is only one approved, specific treatment for COVID-19, the illness caused by the novel coronavirus SARS-CoV-2, albeit with modest efficacy.
Researchers estimate global undercounting of COVID-19 cases
A new study by an international team of researchers and published on the preprint server medRxiv* in July 2020 describes a model to estimate the actual undercounting of COVID-19 cases and the global prevalence.
What people know and how they behave during COVID-19: Canadian perspective
Now, a new study by researchers in Canada and published on the preprint server medRxiv in July 2020 shows that national news is the primary source of information about the pandemic.
AI powered screening-test for COVID-19
A new study by researchers at the University of Oxford and Harvard University and published on the preprint server medRxiv in July 2020 reports the use of artificial intelligence (AI) to screen patients presenting or admitted to hospital for COVID-19. This could help triage patients in low-testing settings and help reduce infection risk.
As winter comes other viruses will compete with SARS-CoV-2 for susceptible hosts
A new study published on the preprint server medRxiv in July 2020 traces how COVID-19 became the predominant cause of respiratory infection in the period from early January until the present.
.png)
No hay comentarios:
Publicar un comentario